Apotea AB (publ)CHIX:APOTES 18 Net Margin % is 4.09% as of Mar. 2026, which is 79% above its 10-year median of 2.29. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 665 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 52.03% on this metric.
The historical rank and industry rank for Apotea AB (publ)'s Net Margin % or its related term are showing as below:
CHIX:APOTEs'
s Net Margin % Range Over the Past 10 Years
Min: 0.41 Med: 2.29 Max: 3.29
Current: 3.2
CHIX:APOTEs's Net Margin % is ranked better than 52.03% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.89
vs CHIX:APOTEs: 3.20
Apotea AB (publ) (CHIX:APOTEs) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Apotea AB (publ) Net Margin % Related Terms
Apotea AB (publ) Net Margin % Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Net Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Net Margin % distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (CHIX:APOTES) has a Net Margin % of 4.09% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Apotea AB (publ) and its competitors. This is 79% above median its historical median of 2.29. Over the past decade, Apotea AB (publ)'s Net Margin % has ranged from 0.41 to 3.29. According to the industry distribution chart, Apotea AB (publ) ranks #319 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 48%.
Is Apotea AB (publ)'s Net Margin % too high?
Apotea AB (publ)'s current Net Margin % of 4.09% is 79% above median its 10-year median of 2.29. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 3.29. The Healthcare Providers & Services industry median Net Margin % is 2.89. Apotea AB (publ)'s value of 4.09% is 41.5% above this industry median. Based on the distribution chart, Apotea AB (publ) ranks #319 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #319 out of 665 companies for Net Margin %. This puts Apotea AB (publ) in the upper half of its industry. The industry median Net Margin % is 2.89. Apotea AB (publ)'s value of 4.09% is 41.5% above this benchmark. Historically, Apotea AB (publ)'s own Net Margin % has ranged from 0.41 to 3.29 over the past decade. While the company's 10-year median is 2.29 vs. the industry median of 2.89, Apotea AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current Net Margin % of 4.09% is 41.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Net Margin % is 4.09%, which is 79% above median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Net Margin % of 4.09%. The current Net Margin % is 4.09%, which is 79% above median its 10-year median of 2.29 and 41.5% above the Healthcare Providers & Services industry median of 2.89. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Net Margin % is 4.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
